Published in Cerebrovasc Dis on November 05, 2009
Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev (2014) 1.76
Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra (2011) 1.05
Racial and gender differences in stroke severity, outcomes, and treatment in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis (2014) 0.95
Safety of intravenous thrombolytic use in four emergency departments without acute stroke teams. Acad Emerg Med (2010) 0.91
The prognostic value of motor-evoked potentials in motor recovery and functional outcome after stroke − a systematic review of the literature. Funct Neurol (2012) 0.90
Stroke Severity Is a Crucial Predictor of Outcome: An International Prospective Validation Study. J Am Heart Assoc (2016) 0.89
Infections present on admission compared with hospital-acquired infections in acute ischemic stroke patients. J Stroke Cerebrovasc Dis (2013) 0.89
Thrombus branching and vessel curvature are important determinants of middle cerebral artery trunk recanalization with Merci thrombectomy devices. Stroke (2012) 0.86
Stroke Survivors Scoring Zero on the NIH Stroke Scale Score Still Exhibit Significant Motor Impairment and Functional Limitation. Stroke Res Treat (2014) 0.84
Added value of CT perfusion compared to CT angiography in predicting clinical outcomes of stroke patients treated with mechanical thrombectomy. Eur Radiol (2016) 0.82
Safety of protocol violations in acute stroke tPA administration. J Stroke Cerebrovasc Dis (2013) 0.82
Anterior choroidal artery ischaemic patterns predict outcome of carotid occlusion. J Neurol Neurosurg Psychiatry (2012) 0.79
Comparative Effectiveness of Prestroke Aspirin on Stroke Severity and Outcome. Ann Neurol (2016) 0.78
Intravenous Thrombolysis is Effective in Young Adults: Results from the Baden-Wuerttemberg Stroke Registry. Front Neurol (2015) 0.76
Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. BMC Neurol (2015) 0.76
Investigating the utility of previously developed prediction scores in acute ischemic stroke patients in the stroke belt. J Stroke Cerebrovasc Dis (2014) 0.75
Intravenous Tissue Plasminogen Activator Improves the Outcome in Very Elderly Korean Patients with Acute Ischemic Stroke. J Stroke (2015) 0.75
Safety of intravenous tissue plasminogen activator administration with computed tomography evidence of prior infarction. J Stroke Cerebrovasc Dis (2014) 0.75
The Itemized NIHSS Scores Are Associated With Discharge Disposition in Patients With Minor Stroke. Neurohospitalist (2016) 0.75
A trial of imaging selection and endovascular treatment for ischemic stroke. N Engl J Med (2013) 9.97
The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke (2007) 8.06
Safety and efficacy of mechanical embolectomy in acute ischemic stroke: results of the MERCI trial. Stroke (2005) 8.05
Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med (2013) 7.00
Transient ischemic attack--proposal for a new definition. N Engl J Med (2002) 4.94
Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA (2004) 4.82
Statistical analysis of the primary outcome in acute stroke trials. Stroke (2012) 3.52
Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation (2011) 3.30
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke (2003) 2.87
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis. Ann Intern Med (2013) 2.87
Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke (2011) 2.80
Magnetic resonance imaging detection of microbleeds before thrombolysis: an emerging application. Stroke (2002) 2.76
MERCI 1: a phase 1 study of Mechanical Embolus Removal in Cerebral Ischemia. Stroke (2004) 2.75
Forecasting the future of stroke in the United States: a policy statement from the American Heart Association and American Stroke Association. Stroke (2013) 2.66
Collaterals dramatically alter stroke risk in intracranial atherosclerosis. Ann Neurol (2011) 2.62
CT and MRI early vessel signs reflect clot composition in acute stroke. Stroke (2011) 2.52
Recommendations on angiographic revascularization grading standards for acute ischemic stroke: a consensus statement. Stroke (2013) 2.50
Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ (2010) 2.42
Comparison of 30-day mortality models for profiling hospital performance in acute ischemic stroke with vs without adjustment for stroke severity. JAMA (2012) 2.38
The smoking-thrombolysis paradox and acute ischemic stroke. Neurology (2005) 2.31
Late secondary ischemic injury in patients receiving intraarterial thrombolysis. Ann Neurol (2002) 2.31
Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke (2011) 2.23
Efficacy of intra-arterial fibrinolysis for acute ischemic stroke: meta-analysis of randomized controlled trials. Stroke (2010) 2.17
Age-related differences in characteristics, performance measures, treatment trends, and outcomes in patients with ischemic stroke. Circulation (2010) 2.15
Perfusion-weighted magnetic resonance imaging thresholds identifying core, irreversibly infarcted tissue. Stroke (2003) 2.06
Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ (2012) 2.04
Indirect revascularization for nonmoyamoya intracranial arterial stenoses: clinical and angiographic outcomes. J Neurosurg (2012) 2.03
Characteristics, performance measures, and in-hospital outcomes of the first one million stroke and transient ischemic attack admissions in get with the guidelines-stroke. Circ Cardiovasc Qual Outcomes (2010) 2.02
Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke (2006) 2.02
Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke (2009) 1.96
A midlife stroke surge among women in the United States. Neurology (2007) 1.86
Strategies used by hospitals to improve speed of tissue-type plasminogen activator treatment in acute ischemic stroke. Stroke (2014) 1.76
Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke (2010) 1.75
Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis (2009) 1.71
Expanding indications for statins in cerebral ischemia: a quantitative study. Arch Neurol (2005) 1.69
Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke (2002) 1.68
Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke. Stroke (2011) 1.67
Risk score for in-hospital ischemic stroke mortality derived and validated within the Get With the Guidelines-Stroke Program. Circulation (2010) 1.66
Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale. Stroke (2009) 1.63
Annual incidence of first silent stroke in the United States: a preliminary estimate. Cerebrovasc Dis (2003) 1.60
Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke. Stroke (2006) 1.59
Efficacy of folic acid supplementation in cardiovascular disease prevention: an updated meta-analysis of randomized controlled trials. Eur J Intern Med (2012) 1.55
Design and rationale of the Mechanical Retrieval and Recanalization of Stroke Clots Using Embolectomy (MR RESCUE) Trial. Int J Stroke (2012) 1.55
Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes (2012) 1.54
Body mass index and hospital discharge outcomes after ischemic stroke. Arch Neurol (2007) 1.54
Prediction of hemorrhagic transformation after recanalization therapy using T2*-permeability magnetic resonance imaging. Ann Neurol (2007) 1.53
Declining stroke and vascular event recurrence rates in secondary prevention trials over the past 50 years and consequences for current trial design. Circulation (2011) 1.51
Relationship of national institutes of health stroke scale to 30-day mortality in medicare beneficiaries with acute ischemic stroke. J Am Heart Assoc (2012) 1.48
Does achieving an intensive versus usual blood pressure level prevent stroke? Ann Neurol (2011) 1.48
Acute Stroke Imaging Research Roadmap II. Stroke (2013) 1.47
Risk of intracranial hemorrhage with protease-activated receptor-1 antagonists. Stroke (2012) 1.44
Multiparametric MRI and CT models of infarct core and favorable penumbral imaging patterns in acute ischemic stroke. Stroke (2012) 1.43
The new standing guideline committee policy of the American Stroke Association Stroke Council. Stroke (2006) 1.42
Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke (2012) 1.41
Safety of intravenous fibrinolysis in imaging-confirmed single penetrator artery infarcts. Stroke (2010) 1.41
Interactions within stroke systems of care: a policy statement from the American Heart Association/American Stroke Association. Stroke (2013) 1.41
The value of arterial spin-labeled perfusion imaging in acute ischemic stroke: comparison with dynamic susceptibility contrast-enhanced MRI. Stroke (2012) 1.40
Early neutrophilia is associated with volume of ischemic tissue in acute stroke. Stroke (2007) 1.40
Comprehensive overview of nursing and interdisciplinary care of the acute ischemic stroke patient: a scientific statement from the American Heart Association. Stroke (2009) 1.38
Outcome analysis in clinical trial design for acute stroke: physicians' attitudes and choices. Cerebrovasc Dis (2008) 1.37
Extending reperfusion therapy for acute ischemic stroke: emerging pharmacological, mechanical, and imaging strategies. Stroke (2005) 1.37
Thrombolytic toxicity: blood brain barrier disruption in human ischemic stroke. Cerebrovasc Dis (2008) 1.37
Evidence of publication bias in reporting acute stroke clinical trials. Neurology (2006) 1.37
Strokes with minor symptoms: an exploratory analysis of the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator trials. Stroke (2010) 1.35
The Los Angeles Motor Scale (LAMS): a new measure to characterize stroke severity in the field. Prehosp Emerg Care (2003) 1.35
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes (2013) 1.31
In-hospital initiation of secondary stroke prevention therapies yields high rates of adherence at follow-up. Stroke (2004) 1.28
Therapeutic milestone: stroke declines from the second to the third leading organ- and disease-specific cause of death in the United States. Stroke (2010) 1.28
Years of disability-adjusted life gained as a result of thrombolytic therapy for acute ischemic stroke. Stroke (2010) 1.28
A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke (2008) 1.24
Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke (2011) 1.22
Cerebral white matter hyperintensities on MRI: Current concepts and therapeutic implications. Cerebrovasc Dis (2006) 1.21
Evolving paradigms in neuroimaging of the ischemic penumbra. Stroke (2004) 1.20
Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke - Comparison with dynamic susceptibility contrast enhanced perfusion imaging. Neuroimage Clin (2013) 1.20
Patterns and predictors of blood-brain barrier permeability derangements in acute ischemic stroke. Stroke (2008) 1.18
Stroke thrombolysis: save a minute, save a day. Stroke (2014) 1.17
Patterns of emergency medical services use and its association with timely stroke treatment: findings from Get With the Guidelines-Stroke. Circ Cardiovasc Qual Outcomes (2013) 1.17
Impact of microalbuminuria on incident stroke: a meta-analysis. Stroke (2010) 1.17
Identifying patients at high risk for poor outcome after intra-arterial therapy for acute ischemic stroke. Stroke (2009) 1.15
High-density lipoprotein cholesterol: an emerging target for stroke treatment. Stroke (2007) 1.14
Randomized, controlled trial of an intervention to enable stroke survivors throughout the Los Angeles County safety net to "stay with the guidelines". Circ Cardiovasc Qual Outcomes (2011) 1.11
Development and validation of a simple conversion model for comparison of intracerebral hemorrhage volumes measured on CT and gradient recalled echo MRI. Stroke (2008) 1.10
Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients. Neurology (2010) 1.09
Validation of computed tomographic middle cerebral artery "dot"sign: an angiographic correlation study. Stroke (2003) 1.08
Impact of baseline tissue status (diffusion-weighted imaging lesion) versus perfusion status (severity of hypoperfusion) on hemorrhagic transformation. Stroke (2010) 1.08
Collateral circulation in symptomatic intracranial atherosclerosis. J Cereb Blood Flow Metab (2010) 1.08
Epidemiological impact in the United States of a tissue-based definition of transient ischemic attack. Stroke (2003) 1.08
Optimizing prediction scores for poor outcome after intra-arterial therapy in anterior circulation acute ischemic stroke. Stroke (2013) 1.07
Predictors of subarachnoid hemorrhage in acute ischemic stroke with endovascular therapy. Stroke (2010) 1.06
Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology (2006) 1.05
Frequency and determinants of pneumonia and urinary tract infection during stroke hospitalization. J Stroke Cerebrovasc Dis (2007) 1.05